Asthma: Cellular and Humoral Mechanisms

Crofton and Douglas's Respiratory Diseases: Fifth Edition

Volumn 2, Issue , 2008, Pages 907-921

  Haslett, Christopher ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Airways; Antigen; Asthma; Granulocytes; Oedema

Indexed keywords

EID: 5644247064     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470695999.ch33     Document Type: Chapter

References (128)

1. Messer JW, Peters GA, Bennett WA. Causes of death and pathologic findings in 304 cases of bronchial asthma. Dis Chest 1960; 38:616.
2. Lungren R, Soderberg M, Horstedt P, Stenling R. Morphological studies on bronchial mucosal biopsies from asthmatics before and after ten years treatment with inhaled steroids. Eur Respir J 1988; 1: 883.
3. Naylor B. The shedding of the mucosa of the bronchial tree in asthma. Thorax 1962; 17: 69.
4. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial respiratory tract in patients with asthma. Am Rev Respir Dis 1985; 131: 599.
5. Dunnill MS. The pathology of asthma, with special reference to the changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27.
6. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med 1992; 30:689.
7. Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissue of patients with bronchial asthma. Lancet 1982; ii: 11.
8. Azzawi M, Bradley B, Jeffrey PK et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142:1407.
9. Godard P, Chaintreuil J, Damon M et al. Functional assessment of alveolar macrophages: comparison of cells from asthmatic and normal subjects. J Allergy Clin Immunol 1982; 70: 88.
10. Flint KC, Leung KB, Hudspith BN, Brostoff J, Pearce FL, Johnson NM. Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. Br Med J 1985; 291: 923.
11. Kelly C, Ward C, Stenton CS, Bird G, Hendricks DJ, Walters EH. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway hyperresponsiveness. Thorax 1988; 43: 684.
12. Wardlaw AJ, Cromwell O, Celestino D et al. Morphological and secretory properties of bronchoalveolar lavage mast cells in respiratory diseases. Clin Allergy 1986; 16: 163.
13. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage fluid and mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 62.
14. Djukanovic R, Roche WR, Wilson JW et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434.
15. Metzger WJ, Zavala D, Richerson HB et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs:description of the model and local airway inflammation. Am Rev Respir Dis 1987; 135:433.
16. Lam S, LeRichie J, Phillips D et al. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar wood asthma. J Allergy Clin Immunol 1987; 80: 44.
17. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils and the magnitude of the allergen induced late-phase response in man. J Immunol 1988; 141: 4158.
18. Pepys J, Hutchcroft BJ. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 1978; 112:829.
19. Gell PGH, Coombs RRA. Clinical Aspects of Immunology, 2nd edn. Oxford: Blackwell, 1968.
20. Ishizaka T, Soto S, Ishizaka K. Mechanisms of passive sensitization. III. Number of IgE molecules and their receptor sites in human basophil granulocytes. J Immunol 1973; 111:500.
21. Booij-Noord H, Orie NGM, de Bries K. Immediate and late bronchial obstructive reactions to house dust mite and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 1971; 48:344.
22. Bradley BL, Azzawi M, Jacobson M et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationships to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88: 661.
23. Spielberg HL. Structure and function of Fc receptors for IgE on lymphocytes, monocytes and macrophages. Adv Immunol 1984; 35: 51.
24. Larick JW, Kunkel SL. The role of tumor necrosis factor and interleukin-1 in the immunoinflammatory response. Pharmacol Res 1988; 5: 129.
25. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44: 153.
26. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045.
27. Walz A, Burgener R, Car B et al. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J Exp Med 1991; 174: 1355.
28. Wolpe SD, Davatelis G, Sherry B et al. Macrophages secrete a novel heparinbinding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988; 167: 570.
29. Schall TJ, Jangstra J, Dyer BJ et al. Ahuman T cell-specific molecule is a member of a new glue family. J Immunol 1988; 141: 1018.
30. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine and autocrine control of inflammatory responses. J Cell Biol 1988; 107: 1269.
31. Le J, Vilcek J. TNF and IL-1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234.
32. Damon M, Chavis C, Godard P, Michel EB, Crastes de Paulet A. Purification and mass spectrometry identification of LTD4, synthesized by human alveolar macrophages. Biochem Biophys Res Commun 1983; 111: 518.
33. Amoux B, Simeos-Caerio MH, Landes A, Mathieu M, Daroux P, Benveniste J. Alveolar macrophages from asthmatic patients release platelet activating factor (PAFacether) and lyso-PAF-acether when stimulated with specific allergens. Am Rev Respir Dis 1982; 125: 70.
34. Campbell AM, Robinson C. Further studies on IgE-mediated eicosanoid release by dispersed lung cells. Br J Pharmacol 1988; 95 (Suppl): 674.
35. Schulman ES, Newball HH, Demers LM, Fitzpatrick FA, Adkinson NF. Anaphylactic release of thromboxane A2, prostaglandin D2 and prostacyclin from human lung parenchyma. Am Rev Respir Dis 1981; 124:402.
36. Robinson C. Mast cells and newlygenerated lipid mediators. In: Holgate ST, ed. Mast Cells, Mediators and Disease. Dordrecht:Kluwer Academic, 1988: 149.
37. Holgate ST, Robinson C, Church MK. Mediators of immediate hypersensitivity. In:Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, eds. Allergy: Principles and Practice. St Louis: Mosby, 1988: 135.
38. Lee TH, Nagakura T, Papageogiou N, Cromwell O, Ikura Y, Kay AB. Mediators in exercise-induced asthma. J Allergy Clin Immunol 1984; 73: 634.
39. Flint KC. Hyperosmolar histamine release from human lung mast cells: its relevance to exercise-induced asthma. In: Flint KC, Hudspith BN, eds. London: Springer Verlag, 1987: 43.
40. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localised to and released by human mast cells. J Exp Med 1992; 176: 1381.
41. Bradding P, Feather IH, Wilson S et al. Immunolocalisation of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol 1993; 151: 3853.
42. Akagi K, Townley RG. Spontaneous histamine release and histamine content in normal subjects with asthma. J Allergy Clin Immunol 1989; 83: 742.
43. Gaddy JH, Busse WW. Enhanced IgEdependent basophil histamine release and airway reactivity in asthma. Am Rev Respir Dis 1986; 134: 969.
44. Sampson D, Archer GT. Release of histamine from human basophils. Blood 1967; 29: 722.
45. Ishizaka TR, De Bernardo R, Tomioka H, Lichtenstein LM, Ishizaka K. Identification of basophil granulocyte as a site of allergic histamine release. J Immunol 1972; 108: 1000.
46. Kaplan AP, Haak-Frendscho M, Fauci A, Dinarello C, Halbert E. Ahistaminereleasing factor from activated human mononuclear cells. J Immunol 1985; 135:2027.
47. MacDonald SM, Lichtenstein LM, Proud D et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987; 139: 506.
48. Columbo M, Casolaro V, Warner JA, McGlashan DW Jr, Kagey-Sabotka A, Lichtenstein LM. The mechanism of mediator release from human basophils induced by platelet-activating factor. J Immunol 1990; 145: 3855.
49. Frigas E, Loegering DA, Solley GO, Farrow GM, Gleich GJ. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 1981; 56: 345.
50. de Monchy JGR, Kauffman HF, Venge P et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373.
51. Horn BR, Robin ED, Theodore J, Van Kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Med 1975; 292: 1152.
52. Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin Allergy 1985; 15: 411.
53. Ellis AG. The pathological anatomy of bronchial asthma. Am J Med Sci 1908; 136: 407.
54. Dunnill MS. Pulmonary Pathology. Edinburgh:Churchill Livingstone, 1982: Chapter 6.
55. Capron M, Capron A, Dessaint JP, Torpier G, Johansson GS, Prin A. Fc receptors for IgE on human and rat eosinophils. J Immunol 1981; 126: 2087.
56. Khalife J, Capron M, Cesbron JY et al. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J Immunol 1986; 137: 1659.
57. Burke LA, Crea REG, Wilkinson JRW, Arm JP, Spur BW, Lee TH. Comparison of the generation of platelet activating factor and leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and the calcoum inophore A23187: the effects of nedocromil sodium. J Allergy Clin Immunol 1990; 85: 26.
58. Cromwell O, Wardlaw AJ, Champion A, Moqbel R, Osei D, Kay AB. IgG-dependent generation of platelet activating factor by normal and low density human eosinophils. J Immunol 1990; 145: 3862.
59. Hubscher T. Role of the eosinophil in allergic reactions. II. Release of prostaglandins from human eosinophilic leukocytes. J Immunol 1975; 114: 1389.
60. Parsons WG, Roberts LJ. Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. J Immunol 1988; 141: 2413.
61. Shaw RJ, Walsh GM, Cromwell O, Moqbel R, Spry CJF, Kay AB. Activated human eosinophils generate SRS-A leukotrienes following physiological (IgG-dependent) stimulations. Nature 1985; 316: 150.
62. Cromwell O, Moqbel R, Fitzharris P et al. Leukotriene C4 generation from human eosinophils stimulated with IgG-Aspergillus fumigatus antigen immune complexes. J Allergy Clin Immunol 1988; 82: 535.
63. Jorg A, Henderson WR, Murphy RC, Klebanoff SJ. Leukotriene generation by eosinophils. J Exp Med 1982; 155: 390.
64. Weller PF, Lee CN, Foster DW, Corey EJ, Susten KF, Lewis RA. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils; predominant production of leukotriene C4. Proc Natl Acad Sci USA 1983; 80: 7625.
65. Turk J, Maas RL, Brash AR, Roberts L, Oates JA. Arachidonic acid and 5-lipoxygenase products from human eosinophils. J Biol Chem 1982; 257: 7068.
66. Moqbel R, Lacy P, Levi-Schaffer F et al. Interleukin-6 is a granule-associated preformed mediator in eosinophils from asthmatic subjects. Am J Respir Crit Care Med 1994; 149: A836.
67. Wardlaw AJ, Moqbel RM, Kay AB. Eosinophils and the allergic inflammatory response. In: Kay AB, ed. Allergy and Allergic Diseases. Oxford: Blackwell Science, 1997:Chapter 10.
68. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992; 148:3543.
69. Murphy KR, Wilson MC, Irvin CG et al. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am Rev Respir Dis 1986; 134: 62.
70. Gajewski TF, Joyce J, Fitch FW. Antiproliferative effect of interferon-g in immune regulation. III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-g. J Immunol 1989; 143: 15.
71. Fiorentino D, Bond HW, Mossmann TR. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 65.
72. Robinson DR, Hamid Q, Ying S et al. Evidence for a predominant 'Th2 type' bronchoalveolar lavage T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298.
73. Corrigan CJ, Hamid Q, North J et al. Peripheral blood CD4, but not CD8 T lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2- type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995; 12:567.
74. Kamei T, Ozaki T, Kawaji K et al. Production of interleukin-5 and granulocyte/macrophage colonystimulating factor by T cells of patients with bronchial asthma in response to Dermatophagoides farinae and its relation to eosinophil colony-stimulating factor. Am J Respir Crit Care Med 1993; 9: 378.
75. Del Prete GF, De Carli M, D'Elios MM et al. Allergens exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23: 1445.
76. Robinson DS, Ying S, Bentley AMet al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993; 92: 397.
77. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNAfor Th2-type (interleukin-4 and interleukin-5) and Th1-type (interleukin-2 and interferon-g) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects. Am J Respir Cell Mol Biol 1995; 12: 477.
78. Virchow JC, Walker C, Hafner D et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995; 151: 960.
79. Wilkens M, Wilkens JH, Busse S et al. Effects of an inhaled PAF antagonist (WEB 2086BS) on allergen-induced early and late asthmatic responses and increased bronchial responsiveness to methacholine. Am Rev Respir Dis 1991; 143: A812.
80. Finney MJB, Karlson JA, Persson CGA. Effects of bronchoconstriction and bronchodilation on a novel human small airway preparation. Br J Pharmacol 1985; 85: 29.
81. Evans TW, Rogers DF, Aursudjij B, Chung KF, Barnes PJ. Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs. Am Rev Respir Dis 1988; 138: 395.
82. Shelhamer J, Marom Z, Kaliner M. Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro. J Clin Invest 1980; 66: 1400.
83. Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuran BL. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 1992; 145: 900.
84. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ. Bradykinin-induced bronchoconstriction in man: mode of action. Am Rev Respir Dis 1987; 135: 176.
85. Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by a neurokinin receptor antagonist. Lancet 1992; 340: 1248.
86. Barnes PJ. Bradykinin and asthma. Thorax 1992; 47: 979.
87. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid- regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992; 89:4888.
88. Liu MC, Hubbard WC, Proud D et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator and permeability changes. Am Rev Respir Dis 1991; 144: 51.
89. Smith HR, Larsen GL, Cherniak RM et al. Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increased airway responsiveness. J Allergy Clin Immunol 1992; 89: 1076.
90. O'Byrne PM, Fuller RW. The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness. Eur Respir J 1989; 2:782.
91. Wenzel SE, Larsen GL, Johnston K, Voelkel NP, Wescott JY. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after allergen challenge. Am Rev Respir Dis 1990; 142: 112.
92. Arm JP, Spur BW, Lee TH. The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol 1988; 82: 654.
93. Kaye MG, Smith LJ. Effects of inhaled leukotriene D4 and platelet activating factor on airway reactivity in normal subjects. Am Rev Respir Dis 1990; 141: 993.
94. Ford-Hutchison AW. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes. Trends Pharmacol Sci 1991; 21:68.
95. Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets: the role of IgE, basophils and a platelet-activating factor. J Exp Med 1972; 136: 1356.
96. Cuss FM, Dixon CMS, Barnes PJ. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986; ii: 189.
97. Evans TW, Chung KF, Rogers DF, Barnes PJ. Effect of platelet activating factor on airway vascular permeability: possible mechanisms. J Appl Physiol 1987; 63: 479.
98. Rogers DF, Alton EWFW, Aursudkij B, Boschetto P, Dewar A, Barnes PJ. Effect of platelet activating factor on formation and composition of airway fluid in the guinea pig trachea. J Physiol 1991; 43: 643.
99. Sanjar S, Smith D, Kings MA, Morley J. Pretreatment with rh-GMCSF, but not rh-IL3, enhances PAF-induced eosinophil accumulation in guinea pig airways. Br J Pharmacol 1990; 100: 399.
100. Kimani G, Tonnesen MG, Henson PG. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet activating factor. J Immunol 1988; 140: 3161.
101. Kroegel C, Yukawa T, Dent G, Chanez P, Chung KF, Barnes PJ. Platelet activating factor induces eosinophil peroxidase release from human eosinophils. Immunology 1988; 64: 559.
102. Kroegel C, Yukawa T, Dent G, Venge P, Chung KF, Barnes PJ. Stimulation of degranulation from human eosoinophils by platelet activating factor. J Immunol 1989; 142: 3518.
103. Adamus WS, Heuer H, Meade CJ, Kempe ER, Brecht HM. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation. Eur J Clin Pharmacol 1988; 35: 237.
104. Hayes J, Ridge SM, Griffiths S, Barnes PJ, Chung KF. Inhibition of cutaneous and platelet responses to platelet activating factor by oral WEB 2086 in man. J Allergy Clin Immunol 1991; 88: 83.
105. Cromwell O, Hamid Q, Corrigan CJ et al. Expression and generation of interleukin-8, IL-6 and granulocyte colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1b and tumour necrosis factor-a. Immunology 1992; 77: 330.
106. Kwon OJ, Collins PD, Au B et al. Glucocorticoid inhibition of TNFa-induced IL-8 gene expression in human primary cultured epithelial cells. Am Rev Respir Dis 1993; 147:A752.
107. Ohno I, Ohkawara Y, Yamauchi K, Tanno Y, Takisima T. Production of tumor necrosis factor with IgE receptor triggering from sensitized lung tissue. Am J Respir Cell Mol Biol 1990; 3: 285.
108. Ohkawara Y, Yamauchi K, Tanno Y et al. Identification of TNF producing cells in sensitized human lung after IgE receptor triggering. Am Rev Respir Dis 1991; 143: 201.
109. Tosi MF, Stark JM, Smith CW, Hamedani A, Gruenert DC, Infeld MD. Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines:effects on neutrophil-epithelial cell adhesion. Am J Respir Cell Mol Biol 1992; 7: 214.
110. Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JSS, Kyan-Aung V, Haskard DO. Tumor necrosis factor combines with IL-4 or IFN-g to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol 1991; 146: 592.
111. Gauchat J-F, Henchoz S, Mazzei G et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365: 340.
112. Schleimer RP, Sterbinsky CA, Kaiser CA et al. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992; 148: 1086.
113. Sanderson CJ. Interleukin-5, eosinophils and disease. Blood 1992; 79: 3101.
114. Broide D, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte-macrophage colonystimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992; 90: 1414.
115. Ohnishi T, Sur S, Collins DS, Fish JE, Gleich GJ, Peters SP. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury 24 hours after segmental antigen lung challenge. J Allergy Clin Immunol 1993; 92: 607.
116. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inhibitory protein 1a induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176: 1489
117. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released from thrombinstimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587.
118. Jose PH, Griffiths-Johnson DA et al. Eotaxin:a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179: 881.
119. Fabbri LM, Boschetto P, Zocca E. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis 1987; 136:36.
120. Aalbers R, Kauffman HF, Vrugt B et al. Bronchial lavage and bronchoalveolar lavage in allergen-induced single early and dual asthmatic responders. Am Rev Respir Dis 1993; 147: 76.
121. Gonzalez MC, Diaz P, Galleguilos FR, Ancic P, Cromwell O, Kay AB. Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T cells in asthma: relative increases in OKT8 cells in single early responders compared with those in late-phase responders. Am Rev Respir Dis 1987; 136: 600.
122. Beasley R, Roche WR, Roberts AJ, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806.
123. Wegner CD, Gundel RH, Reilly N, Haynes L, Letts G, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247: 456.
124. Bentley AM, Durham SR, Robinson DS et al. Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady state and allergen-induced asthma. J Allergy Clin Immunol 1993; 92: 857.
125. Bentley AM, Qui Meng, Robinson DS et al. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for IL-5 and GM-CSF in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8:35.
126. Thomson NC. In vivo versus in vitro human airway responsiveness to different pharmacologic stimuli. Am Rev Respir Dis 1987; 136:S58.
127. Barnes PJ. Asthma as an axon reflex. Lancet 1986; i: 242.
128. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; i: 520.